News

Healio4m
CagriSema confers ‘robust’ weight loss in patients with obesity, with or without diabetes
The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared ...
Novo Nordisk obesity shot tied to greater weight loss at lower doses
Patients who took a lower dose lost more weight on average. Read more at straitstimes.com. Read more at straitstimes.com.